Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

24.10.2019 | Original Contributions | Ausgabe 8/2019

Zeitschrift für Gerontologie und Geriatrie 8/2019

Association between EU guidelines and vaccination in Germany between 2011 and 2017

How healthcare legislation of the EU has influenced access to vaccination for senior citizens in Germany since 2011

Zeitschrift für Gerontologie und Geriatrie > Ausgabe 8/2019
German Managed Care Association Benjamin Azadi
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s00391-019-01638-9) contains supplementary material, which is available to authorized users.



Every fourth citizen within the 28 European Union (EU) member states is over the age of 65 years. In connection with the increasing numbers of senior citizens, vaccinations have become even more important as preventive measures. Vaccines are an established preventive measure and help to ensure that many diseases no longer have a fatal outcome. With respect to the health economic as well as preventive advantages of vaccines, there is possibly a considerable benefit for the EU to support the vaccination program for older patients within the framework of the demographic shift. Since 2011 the EU addresses the demographic change and has thereby placed the possible chances and risks on the agenda.


By focussing on Germany as an EU member state, the question whether the EU guidelines had an influence on vaccination access for senior citizens in the years 2011–2017 was analyzed. It is discussed if a healthcare policy influence was pursued, regardless of not having a unified EU healthcare system.

Material and methods

The EUR-lex database was searched for relevant EU policies regarding vaccination and older patients between February 2011 and May 2017. Results were then discussed within four expert interviews, which were from industry, academia, politics and physician practice.


Overall, four relevant EU policies since 2011 were selected. The discussion resolves that the initiative of the EU to promote the healthcare of senior citizens (EMA Geriatric Medicines Strategy) and the Clinical trials – Regulation EU from 2014 had a significant impact on vaccination access. Due to the EU national policies in Germany were initiated, which had an effect on national level to this specific risk group and vaccination access.


Other than expected, the EU has a passive influence on the healthcare policy transformation on a national level; however, it should be noted that initiatives in politics are always influenced by several impulses. Hereby, a deeper analysis should be considered, which includes the policy action campaigns by multinational stakeholders.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Zeitschrift für Gerontologie und Geriatrie


• Themenbezogene Hefte behandeln Fragen der Gerontologie, der Biologie und Grundlagenforschung des Alterns und der geriatrischen Forschung

• Erweitert mit Beiträgen zu Therapie, Psychologie und Soziologie sowie der praktischen Altenpflege.  

• Hot topics von Experten knapp, aussagekräftig und provokativ kommentiert

Nur für berechtigte Nutzer zugänglich
Über diesen Artikel

Weitere Artikel der Ausgabe 8/2019

Zeitschrift für Gerontologie und Geriatrie 8/2019 Zur Ausgabe

Journal Club

Journal Club

Mitteilungen der DGG

Mitteilungen der DGG